Tacrolimus eye drop (Xingqi Pharmaceutical)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameTacrolimus eye drop (Xingqi Pharmaceutical)
Drug Alias NameSQ-708
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionFK506-binding protein 1A modulatorsCalcineurin modulators
TargetsFK506-binding protein 1ACalcineurin
Therapy Area/IndicationsKeratoplasty rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenyang Xingqi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Xingqi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsKeratoplasty rejection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A